State Of Wisconsin Investment Board Sage Therapeutics, Inc. Transaction History

State Of Wisconsin Investment Board

$37.8 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$10.58 - $17.9 $23,318 - $39,451	-2,204 Reduced 5.62%	37,015 $401,000
Q1 2024 May 14, 2024	SELL	$18.62 - $26.95 $129,781 - $187,841	-6,970 Reduced 15.09%	39,219 $734,000
Q4 2023 Feb 12, 2024	BUY	$17.1 - $22.26 $21,426 - $27,891	1,253 Added 2.79%	46,189 $1 Million
Q3 2023 Nov 14, 2023	SELL	$16.75 - $48.98 $74,537 - $217,961	-4,450 Reduced 9.01%	44,936 $924,000
Q2 2023 Aug 14, 2023	SELL	$40.65 - $59.54 $81 - $119	-2 Reduced -0.0%	49,386 $2.32 Million
Q1 2023 May 15, 2023	SELL	$37.27 - $46.57 $159,552 - $199,366	-4,281 Reduced 7.98%	49,388 $2.07 Million
Q4 2022 Feb 14, 2023	SELL	$32.2 - $43.61 $4,475 - $6,061	-139 Reduced 0.26%	53,669 $2.05 Million
Q3 2022 Nov 14, 2022	SELL	$32.28 - $43.27 $116,369 - $155,988	-3,605 Reduced 6.28%	53,808 $2.11 Million
Q2 2022 Aug 15, 2022	BUY	$27.52 - $37.99 $267,989 - $369,946	9,738 Added 20.43%	57,413 $1.85 Million
Q1 2022 May 13, 2022	BUY	$30.71 - $45.71 $1.27 Million - $1.89 Million	41,428 Added 663.17%	47,675 $1.58 Million
Q4 2021 Feb 11, 2022	SELL	$37.06 - $47.11 $7,152 - $9,092	-193 Reduced 3.0%	6,247 $266,000
Q3 2021 Nov 12, 2021	BUY	$40.26 - $57.37 $12,239 - $17,440	304 Added 4.95%	6,440 $285,000
Q2 2021 Aug 12, 2021	SELL	$54.88 - $79.29 $19,427 - $28,068	-354 Reduced 5.45%	6,136 $349,000
Q1 2021 May 17, 2021	SELL	$70.65 - $96.76 $6,641 - $9,095	-94 Reduced 1.43%	6,490 $486,000
Q4 2020 Feb 03, 2021	SELL	$58.41 - $89.06 $15,770 - $24,046	-270 Reduced 3.94%	6,584 $570,000
Q3 2020 Nov 16, 2020	BUY	$41.13 - $62.45 $2,467 - $3,747	60 Added 0.88%	6,854 $419,000
Q2 2020 Aug 12, 2020	SELL	$25.95 - $43.15 $6,228 - $10,356	-240 Reduced 3.41%	6,794 $282,000
Q1 2020 May 06, 2020	SELL	$26.15 - $77.24 $629,482 - $1.86 Million	-24,072 Reduced 77.39%	7,034 $202,000
Q4 2019 Feb 14, 2020	BUY	$60.18 - $154.77 $1.44 Million - $3.71 Million	23,962 Added 335.41%	31,106 $2.25 Million
Q3 2019 Nov 12, 2019	SELL	$140.29 - $189.96 $7,575 - $10,257	-54 Reduced 0.75%	7,144 $1 Million
Q2 2019 Aug 14, 2019	SELL	$157.85 - $183.09 $302,598 - $350,983	-1,917 Reduced 21.03%	7,198 $1.32 Million
Q1 2019 May 13, 2019	BUY	$89.33 - $163.65 $35,732 - $65,460	400 Added 4.59%	9,115 $1.45 Million
Q3 2018 Nov 14, 2018	SELL	$138.11 - $169.04 $26,655 - $32,624	-193 Reduced 2.17%	8,715 $1.23 Million
Q2 2018 Aug 03, 2018	SELL	$140.36 - $175.76 $4.79 Million - $5.99 Million	-34,092 Reduced 79.28%	8,908 $1.39 Million
Q1 2018 May 07, 2018	BUY	$152.15 - $192.33 $760,750 - $961,650	5,000 Added 13.16%	43,000 $6.93 Million
Q4 2017 Feb 08, 2018	BUY	$60.72 - $167.34 $283,319 - $780,808	4,666 Added 14.0%	38,000 $6.26 Million
Q3 2017 Nov 01, 2017	BUY	$61.4 - $88.52 $2.05 Million - $2.95 Million	33,334	33,334 $2.08 Million

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Account